These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease]. Streit M, Thiel E, Kreuser ED. Dtsch Med Wochenschr; 1995 Aug 04; 120(31-32):1093-9. PubMed ID: 7641593 [No Abstract] [Full Text] [Related]
35. Secondary myelodysplastic syndromes and acute leukemias. Zeidman A, Dayan DB, Mittelman M. Haematologia (Budap); 1995 Aug 04; 27(1):23-8. PubMed ID: 12051292 [Abstract] [Full Text] [Related]
36. [Therapy-related myelodysplastic syndrome (t-MDS)]. Yoshida Y. Ryoikibetsu Shokogun Shirizu; 1998 Aug 04; (22 Pt 3):206-8. PubMed ID: 9851122 [No Abstract] [Full Text] [Related]
37. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Kröger N, Brand R, van Biezen A, Cahn JY, Slavin S, Blaise D, Sierra J, Zander A, Niederwieser D, de Witte T, Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant; 2006 Jan 04; 37(2):183-9. PubMed ID: 16299545 [Abstract] [Full Text] [Related]
40. Myelodysplastic syndrome in a child with a history of medulloblastoma. Akyüz C, Emir S, Güler N, Tüker A, Büyükpamukçu M. Turk J Pediatr; 1998 Jan 04; 40(1):131-4. PubMed ID: 9673540 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]